Caffeine is consumed by over 80% of U.S. adults. This review examines the effects caffeine has on cognitive and physical function, since most real-world activities require complex decision making, motor processing and movement. Caffeine exerts its effects by blocking adenosine receptors. Following low (∼40mg or ∼0.5mgkg -1 ) to moderate (∼300mg or 4mgkg -1 ) caffeine doses, alertness, vigilance, attention, reaction time and attention improve, but less consistent effects are observed on memory and higher-order executive function, such as judgment and decision making. Effects on physical performance on a vast array of physical performance metrics such as time-to-exhaustion, time-trial, muscle strength and endurance, and high-intensity sprints typical of team sports are evident following doses that exceed about 200mg (∼3mgkg -1 ). Many occupations, including military, first responders, transport workers and factory shift workers, require optimal physical and cognitive function to ensure success, workplace safety and productivity. In these circumstances, that may include restricted sleep, repeated administration of caffeine is an effective strategy to maintain physical and cognitive capabilities.
Keywords: Adenosine receptors; Attention; Energy drinks; High-intensity sprints; Muscle strength and power; Reaction time; Restricted sleep; Sustained wakefulness; Time-to-exhaustion; Time-trial; Vigilance.
Published by Elsevier Ltd.
Kamimori GH, McLellan TM, Tate CM, Voss DM, Niro P, Lieberman HR. Kamimori GH, et al. Psychopharmacology (Berl). 2015 Jun;232(12):2031-42. doi: 10.1007/s00213-014-3834-5. Epub 2014 Dec 21. Psychopharmacology (Berl). 2015. PMID: 25527035 Free PMC article. Clinical Trial.
Lieberman HR, Tharion WJ, Shukitt-Hale B, Speckman KL, Tulley R. Lieberman HR, et al. Psychopharmacology (Berl). 2002 Nov;164(3):250-61. doi: 10.1007/s00213-002-1217-9. Epub 2002 Sep 5. Psychopharmacology (Berl). 2002. PMID: 12424548 Clinical Trial.
Killgore WD, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ. Killgore WD, et al. J Sleep Res. 2008 Sep;17(3):309-21. doi: 10.1111/j.1365-2869.2008.00654.x. Epub 2008 Jun 2. J Sleep Res. 2008. PMID: 18522689 Clinical Trial.
Ganio MS, Klau JF, Casa DJ, Armstrong LE, Maresh CM. Ganio MS, et al. J Strength Cond Res. 2009 Jan;23(1):315-24. doi: 10.1519/JSC.0b013e31818b979a. J Strength Cond Res. 2009. PMID: 19077738 Review.
Gahr M. Gahr M. Fortschr Neurol Psychiatr. 2020 May;88(5):318-330. doi: 10.1055/a-0985-4236. Epub 2019 Oct 14. Fortschr Neurol Psychiatr. 2020. PMID: 31610604 Review. German.
Soltani Rad MN, Behrouz S, Charbaghi M, Behrouz M, Zarenezhad E, Ghanbariasad A. Soltani Rad MN, et al. RSC Adv. 2024 Aug 22;14(36):26674-26693. doi: 10.1039/d4ra04787g. eCollection 2024 Aug 16. RSC Adv. 2024. PMID: 39175679 Free PMC article.
Ghanem KZ, Ramadan MM, Mohammed AT, Mahmoud AE, Babintsev K, Elmessery WM, El-Messery TM. Ghanem KZ, et al. Heliyon. 2024 Aug 3;10(15):e35685. doi: 10.1016/j.heliyon.2024.e35685. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170107 Free PMC article.
Alejandro Juárez RP, Celia AC. Alejandro Juárez RP, et al. Rev Cient Odontol (Lima). 2024 Jun 27;12(2):e197. doi: 10.21142/2523-2754-1202-2024-197. eCollection 2024 Apr-Jun. Rev Cient Odontol (Lima). 2024. PMID: 39119121 Free PMC article. Spanish.
Zajkowska I, Niczyporuk P, Urbaniak A, Tomaszek N, Modzelewski S, Waszkiewicz N. Zajkowska I, et al. Nutrients. 2024 Jul 11;16(14):2228. doi: 10.3390/nu16142228. Nutrients. 2024. PMID: 39064675 Free PMC article. Review.
Hassen HBH, Ammar A, Machfer A, Fkih N, Erriahi S, Hamdi S, Chtourou H, Bouzid MA. Hassen HBH, et al. Brain Sci. 2024 Jul 13;14(7):701. doi: 10.3390/brainsci14070701. Brain Sci. 2024. PMID: 39061441 Free PMC article.